Search Ontology:
ChEBI
ergothioneine
- Term ID
- CHEBI:4828
- Synonyms
-
- (2S)-3-(2-mercapto-1H-imidazol-5-yl)-2-(trimethylammonio)propanoate
- (2S)-3-(2-mercapto-1H-imidazol-5-yl)-2-(trimethylazaniumyl)propanoate
- (alphaS)-alpha-carboxy-2,3-dihydro-N,N,N-trimethyl-2-thioxo-1H-imidazole-4-ethanaminium inner salt
- (S)-(1-carboxy-2-(2-mercaptoimidazol-4-yl)ethyl)trimethylammonium hydroxide
- 2-mercaptohistidine trimethylbetaine
- 3-(2-sulfanylidene-1,3-dihydroimidazol-4-yl)-2-trimethylammonio-propanoate
- ergothioneine thiol
- ergothionine
- erythrothioneine
- L-ergothioneine
- L-thioneine
- sympectothion
- thiolhistidine-betaine
- thiolhistidinebetaine
- Definition
- A L-histidine derivative that is N(alpha),N(alpha),N(alpha)-trimethyl-L-histidine in which the hydrogen at position 2 on the imdazole ring is replaced by a mercapto group. A naturally occurring metabolite of histidine synthesized by bacteria and fungi with antioxidant properties. It is found ubiquitously in plants and animals and is present in many human foodstuffs.
- References
-
- Beilstein:5755696
- CAS:497-30-3
- HMDB:HMDB0003045
- KEGG:C05570
- MetaCyc:CPD-15276
- PMID:15030958
- PMID:15744438
- PMID:17616140
- PMID:18670092
- PMID:18841979
- PMID:19660151
- PMID:19911007
- PMID:20420449
- PMID:23418129
- PMID:23494799
- PMID:23922985
- PMID:24392160
- PMID:25154712
- PMID:25736892
- PMID:26079795
- PMID:26149121
- PMID:26229105
- PMID:26338495
- PMID:26412552
- PMID:26542137
- PMID:26579093
- PMID:26634964
- PMID:26713511
- PMID:26772879
- PMID:26774486
- PMID:26921894
- PMID:26994919
- PMID:27101740
- PMID:27134772
- PMID:27306320
- PMID:27444382
- PMID:7144630
- Reaxys:5755696
- Reaxys:8411606
- Wikipedia:Ergothioneine
- Ontology
- ChEBI ( EBI )
- Resources
- CTD
- is a type of
-
- has_role
-
- inverse has_functional_parent
-
- inverse is_conjugate_acid_of
-
- inverse is_tautomer_of
-
- is_conjugate_base_of
-
- is_tautomer_of
-
Phenotype
Phenotype resulting from ergothioneine
Phenotype where environments contain ergothioneine
Phenotype modified by environments containing ergothioneine
Human Disease Model